SDGRSchrödinger, Inc.

$935M

Q2 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$38M+29.2% YoY

Gross Profit

$17M44.5% margin

Operating Income

-$43M-113.0% margin

Net Income

-$48M-124.0% margin

EPS (Diluted)

$-0.67

QoQ Revenue Growth

-20.9%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$27M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$688M

Total Liabilities

$195M

Stockholders' Equity

$493M

Cash & Equivalents

$127M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$30M	+29.2%
Gross Profit	$17M	$12M	+43.0%
Operating Income	-$43M	-$30M	-43.3%
Net Income	-$48M	-$35M	-37.6%

Revenue Segments

Software Products And Services

$30M28%

Revenue From Contract With Customer Before Contribution

$29M27%

On Premise Software

$17M16%

Drug Discovery

$8M8%

Drug Discovery Services Revenue From Contracts With Customers

$8M8%

Maintenance

$5M5%

Professional Services

$4M4%

Hosted Software

$4M3%

Drug Discovery Services

$1M1%

Contribution

$1M1%

Geographic Segments

UNITED STATES

$27M70%

Europe

$5M13%

Non Us

$3M9%

JAPAN

$3M8%